文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.

作者信息

Quirino Angela, Marascio Nadia, Branda Francesco, Ciccozzi Alessandra, Romano Chiara, Locci Chiara, Azzena Ilenia, Pascale Noemi, Pavia Grazia, Matera Giovanni, Casu Marco, Sanna Daria, Giovanetti Marta, Ceccarelli Giancarlo, Alaimo di Loro Pierfrancesco, Ciccozzi Massimo, Scarpa Fabio, Maruotti Antonello

机构信息

Unit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University of Catanzaro "Renato Dulbecco" Teaching Hospital, 88100 Catanzaro, Italy.

Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.

出版信息

Pathogens. 2024 Sep 5;13(9):766. doi: 10.3390/pathogens13090766.


DOI:10.3390/pathogens13090766
PMID:39338957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11435051/
Abstract

Viral hepatitis is a major cause of liver illness worldwide. Despite advances in the understanding of these infections, the pathogenesis of hepatitis remains a complex process driven by intricate interactions between hepatitis viruses and host cells at the molecular level. This paper will examine in detail the dynamics of these host-pathogen interactions, highlighting the key mechanisms that regulate virus entry into the hepatocyte, their replication, evasion of immune responses, and induction of hepatocellular damage. The unique strategies employed by different hepatitis viruses, such as hepatitis B, C, D, and E viruses, to exploit metabolic and cell signaling pathways to their advantage will be discussed. At the same time, the innate and adaptive immune responses put in place by the host to counter viral infection will be analyzed. Special attention will be paid to genetic, epigenetic, and environmental factors that modulate individual susceptibility to different forms of viral hepatitis. In addition, this work will highlight the latest findings on the mechanisms of viral persistence leading to the chronic hepatitis state and the potential implications for the development of new therapeutic strategies. Fully understanding the complex host-pathogen interactions in viral hepatitis is crucial to identifying new therapeutic targets, developing more effective approaches for treatment, and shedding light on the mechanisms underlying progression to more advanced stages of liver damage.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/11435051/244c90ba7d51/pathogens-13-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/11435051/244c90ba7d51/pathogens-13-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/11435051/244c90ba7d51/pathogens-13-00766-g001.jpg

相似文献

[1]
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.

Pathogens. 2024-9-5

[2]
A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses.

Gastroenterology. 2012-1

[3]
Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections.

Rev Med Virol. 2019-7-19

[4]
Immunopathogenesis of chronic hepatitis B.

World J Gastroenterol. 2014-10-21

[5]
Rolling review--the pathogenesis, diagnosis and management of viral hepatitis.

Aliment Pharmacol Ther. 1994-4

[6]
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches.

Int J Mol Sci. 2024-8-29

[7]
Current perspectives of viral hepatitis.

World J Gastroenterol. 2024-5-14

[8]
Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.

Infect Genet Evol. 2017-8-12

[9]
Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response.

Front Cell Infect Microbiol. 2017-6-13

[10]
Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence.

Ann Hepatol. 2016

引用本文的文献

[1]
Investigation of Serum Nitric Oxide, Zinc, Copper, and C-Reactive Protein Levels in Acute Hepatitis B Patients.

Biol Trace Elem Res. 2025-8-15

[2]
Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study.

PLoS One. 2025-7-21

[3]
Silent sabotage: How hepatitis B virus-miR-3 disarms innate immunity through cGAS-STING suppression.

World J Hepatol. 2025-6-27

[4]
The Dual Role of TRADD in Liver Disease: From Cell Death Regulation to Inflammatory Microenvironment Remodeling.

Int J Mol Sci. 2025-6-19

[5]
Deciphering Host-Virus Interactions and Advancing Therapeutics for Chronic Viral Infection.

Viruses. 2025-3-10

[6]
Potential Benefits of In Silico Methods: A Promising Alternative in Natural Compound's Drug Discovery and Repurposing for HBV Therapy.

Pharmaceuticals (Basel). 2025-3-16

本文引用的文献

[1]
Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes.

Viruses. 2024-5-8

[2]
Deregulation of immune response contributing to fulminant hepatitis in HEV infected pregnant women.

J Med Virol. 2024-5

[3]
Severe hepatitis E virus genotype 3b in a patient with alcohol‑associated liver disease: A case report.

Med Int (Lond). 2024-3-7

[4]
Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.

Front Immunol. 2024

[5]
Hepatitis E virus infection increases the risk of obstetric complications and perinatal adverse outcomes in pregnant women with chronic hepatitis B virus infection.

Eur Rev Med Pharmacol Sci. 2024-3

[6]
Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity.

J Hepatol. 2024-7

[7]
Hecolin vaccine: long-term efficacy against HEV for a three-dose regimen.

Lancet. 2024-3-2

[8]
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet. 2024-3-2

[9]
Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity.

Int J Mol Sci. 2023-12-23

[10]
Hepatitis E infection: A review.

World J Virol. 2023-12-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索